lyophilization comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-02. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
The peptide backbone contains 39 amino acids and includes alpha-aminoisobutyric acid residues, which are not among the standard proteinogenic set. A C20 fatty diacid moiety is attached through a linker, allowing the compound to bind serum albumin and extend its circulation time. This albumin binding is the main reason the molecule supports once-weekly administration rather than more frequent dosing. The measured molecular mass is approximately 4,813 daltons, placing it firmly in the peptide rather than small-molecule class.
Tirzepatide is a synthetic peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual agonist profile distinguishes it from earlier incretin-based compounds that act on a single receptor. The molecule was engineered from the native GIP sequence and carries several non-natural residues that slow enzymatic breakdown. Researchers designed it to combine the insulinotropic effects of GIP signaling with the appetite and gastric-emptying effects associated with GLP-1 activation.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Unmodified peptide backbone |
| Molecular mass | approx. 4,813 Da | 39-residue linear chain |
| Receptor targets | GIP and GLP-1 | Dual agonist activity |
| Route | Subcutaneous injection | Weekly administration interval |
| Elimination half-life | approx. 5 days | Supports weekly dosing schedule |
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Purified material is typically handled as a lyophilized powder kept at or below minus twenty degrees Celsius, shielded from light and moisture. In that state the solid remains stable for extended periods, although repeated freeze-thaw cycling can encourage aggregation. Once dissolved, aqueous solutions are less durable and are generally held cold and used within a brief window. Buffer composition, pH and ionic strength all influence degradation rates, and mildly acidic to neutral conditions are commonly examined. Actual shelf life depends on formulation, concentration and container, so stability limits are established experimentally rather than assumed.
A small 2002 study demonstrated that treatment twice daily for six weeks with crude onion juice from Australian brown onion, re-growth hair on alopecia areata (spot baldness) in 86.9% of the 23 participants. Twice as many flavonols are found in red onion than in yellow onion. Also, non-organic onions might contain pesticides on the peel and in the first scaly leaf. Compounds found in onion that stimulate hair growth:
New company developments included new instrumentation for robotics and detection of DNA fragments using the company's fluorescent labelling. Also in 1990, the U.S. government approved financing to support the Human Genome Project. Dr. James D. Watson, who founded the consortium, forecast that the project could be completed in 15 years from its 1990 starting date, at a cost of cost US$3 billion. Over the next couple years, Japan began a project to sequence the rice genome, and other laboratories initiated programs to sequence the mouse, fruit fly, and yeast genomes. In 1991, Applied sales revenue grew slightly, to almost $164 million, with consumables and service contracts up by 24% to account for 47% of total sales, and DNA sequencer and DNA synthesis instruments having record sales. Forty-five new consumable products and six new instruments were introduced. In 1992, sales revenue grew by more than 11% to over $182 million, with Europe representing 25% of revenue, and Asia and the Pacific Rim accounting for 26%. The company formed a new subsidiary, Lynx Therapeutics, Inc., to focus on antisense DNA research in the area of therapeutics for chronic myelogenous leukemia, melanoma, colorectal cancer, and AIDS.
viticella) and its cultivars). Montana Group: Cultivars belonging to, or derived from, species classified in section Montanae (Schneider) Grey-Wilson such as C. chrysocoma, C. montana, C. spooneri. Tangutica Group: Cultivars with at least one parent belonging to, or derived from, species classified in section Meclatis (Spach) Baill., such as C. intricata, C. ladakhiana, C. orientalis, C. serratifolia, C. tangutica, C. tibetana. This Group has also been known as the Orientalis Group. Texensis Group: Cultivars derived from C. texensis crossed with representatives from either of the Large-flowered Groups. Viorna Group: Cultivars with at least one parent belonging to, or derived from, species classified in section Viorna A. Gray, such as C. crispa, C. fusca, C. ianthina, C. pitcheri, C. reticulata, C. texensis, C. viorna. Cultivars assigned to Texensis Group, and cultivars with C. integrifolia in their parentage, are excluded. Vitalba Group: Cultivars with at least one parent belonging to, or derived from, species classified in section Clematis L., such as C. ligusticifolia, C. potaninii, C. vitalba, C. virginiana. Viticella Group: Cultivars with at least one parent mainly derived from C. viticella. Excludes hybrids between C. integrifolia and C. viticella: see Integrifolia Group. Large-flowered Division: Flowers (5–)10–22(–29) cm across, usually flat. Early Large-flowered Group: Comprises the former Patens Group and Fortunei Group. Cultivars of the Patens Group were derived mainly from C. patens, either directly or indirectly.
=== Broader negative impact on science === Just as the impact factor has attracted criticism for various immediate problems associated with its application, so has there also been criticism that its application undermines the broader process of science. Research has indicated that bibliometrics figures, particularly the impact factor, decrease the quality of peer review an article receives, cause a reluctance to share data, decrease the quality of articles, and a reduce the scope of publishable research. "For many researchers the only research questions and projects that appear viable are those that can meet the demand of scoring well in terms of metric performance indicators—and chiefly the journal impact factor." Furthermore, the process of publication and science is slowed down—authors automatically try to publish with the journals with the highest impact factor—"as editors and reviewers are tasked with reviewing papers that are not submitted to the most appropriate venues".
Its objectives include comparison of survival, cardiovascular mortality and morbidity, pharmacological activity (e.g., suppression of testosterone levels), other side effects and toxicities, and quality of life. In addition to the PATCH trial, the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) study added a high-dose estradiol patches arm (~2,000 men) in July 2017. Estradiol patches are associated with local skin reactions and such as irritation in 14.2% of individuals (with reservoir patches), mild-to-moderate erythema (redness) in 50 to 60% of individuals, and allergic reactions due to cutaneous sensitization. Up to 5% of people using reservoir patches may discontinue therapy due to skin reactions. Visible adhesive residues are also often left by estradiol patches following their removal. Transdermal estradiol gel can serve as an alternative to transdermal estradiol patches for individuals who experience intolerable skin reactions with them. Estradiol patches should not be applied to the breast as this may result in high local levels of estradiol in the breasts and hence an increased likelihood of breast tenderness.
Sources: en.wikipedia.org
The PSOE re-validated its 2004 triumph in the general election of March 2008, although it still did not reach the absolute majority. This time, Rodríguez Zapatero did not want to negotiate any support to achieve the investiture as President of the Government, so he was elected only with the votes of his party on April 11, 2008. In this second legislature, the economic outlook not only did not improve but worsened notably from September 2008 onwards as a consequence of the impact of the international crisis triggered by the bankruptcy of the US investment bank Lehman Brothers. Unemployment soared, initially in the construction sector – the Spanish property bubble also burst – and then in the rest of the sectors, with the emigrants being the most affected. The government, which found it difficult to recognize the seriousness of the crisis, responded with the implementation of economic policy measures typically Keynesian, among which stood out the Spanish Plan for the Stimulus of the Economy, better known as "Plan E" and approved by the end of 2008. However, GDP fell by 3.7% in 2009 and the unemployment rate exceeded 20% of the active population. As a consequence of the increase in spending to stimulate demand and the fall in revenues due to the recession, the public deficit soared to close to 10% of GDP.
Many woody plants regrow around injuries, such as those caused by pruning. In time, such regrowth often completely covers the damaged area as the cambium growth layer produces new tissues. Well-pruned trees with undamaged branch collars often recover well, where poorly-pruned trees rot below the wound.
Similarly, in the North Korean context, "Arduous March" does not directly refer to economic hardship, but a firm resolve to carry out tasks of the party. In June 2021, Kim Jong Un called a meeting to sack several officials over a "severe" COVID-19 breach and warned of a great crisis caused by the pandemic in the country. Despite this, the recently demoted Pak Jong-chon was promoted up to secretary of the Party Central Committee, and rejoined the Politburo as a full member. American activist Tim A. Peters said that there were signs of "enormous stress on the North Korean population" due to the pandemic and associated restrictions, and that he suspected COVID-19 was spreading within the country despite the lack of confirmed cases. In July 2021, North Korea rejected shipments of around two million doses of the Oxford-AstraZeneca vaccine, citing concerns over potential side effects. The same month, Russia also offered to supply the country with its own Sputnik V vaccine on multiple occasions. In September 2021, the country rejected three million doses of the Chinese CoronaVac vaccine which were offered to it under the COVAX programme, asking that the doses be reallocated to other nations. On 27 August, the WHO reported that 37,291 people with flu-like symptoms had so far been tested for COVID-19 in the country, with all testing negative. In October 2021, it was reported by NK News that money coupons were becoming widespread in North Korea, due to COVID-19 controls reportedly causing cash printing issues.
==== Peanut tofu ==== In the Ryukyu Islands, jīmāmi-dōfu (ジーマーミ豆腐) a peanut milk, made by crushing raw peanuts, adding water and straining, is combined with starch (usually sweet potato, known locally as nmukuji, nmukashi (芋澱粉) and heated until curdling occurs. The Chinese equivalent is 落花生豆腐 luòhuāshēng dòufu.
Sources: en.wikipedia.org
==== Behavioral repertoire ==== The broaden-and-build theory of positive emotions suggests positive emotions (e.g. happiness, interest, anticipation) broaden one's awareness and encourage novel, varied, and exploratory thoughts and actions. Over time, this broadened behavioral repertoire builds skills and resources. For example, curiosity about a landscape becomes valuable navigational knowledge; pleasant interactions with a stranger become a supportive friendship; aimless physical play becomes exercise and physical excellence. Positive emotions are contrasted with negative emotions, which prompt narrow survival-oriented behaviors. For example, the negative emotion of anxiety leads to the specific fight-or-flight response for immediate survival.
== Scope == Established in 1981, this facility is a National Science Foundation research facility. It is operated by both the Physics Department and the Geosciences Department of the University of Arizona. It is tasked with both scientific inquiry and education. Topical coverage of investigations includes archaeology, art history, forensic science, radioactive tracer studies, radiometric dating, the carbon cycle, cosmic ray physics, meteorites, geology, paleoclimate, faunal extinctions, hydrologic balance, frequency rate of forest fires, terrestrial magnetic field, solar wind, ocean sciences and instrument development.
== Development == Episode Two was the second in a planned trilogy of shorter episodic games that would continue the story of Half-Life 2 (2004). It was developed simultaneously with Episode One (2006) by a team led by David Speyrer. This schedule of simultaneous development aided them in streamlining the story between the two games to create an immersive story. The technology used was the same for both games, allowing the development teams to quickly fix any technical problems that might arise from either game; this happened often because of the multi-platform release. The team originally planned the ending to feature a comical sequence with Lamarr, Kleiner's pet headcrab, floating in space outside the rocket Gordon launches into space; however, Valve president Gabe Newell requested killing off a major character to create a cliffhanger for Episode Three. On July 13, 2006, Valve announced that Episode Two would be released on Xbox 360 and PlayStation 3 in addition to Windows. Valve handled the development for the PC and Xbox 360, while Electronic Arts (EA) worked on the PlayStation 3 version. It was announced on September 7, 2007, that the PlayStation 3 version would be delayed because the EA studio behind the game was in the United Kingdom, away from Valve's development team, and therefore lagged behind in its schedule. According to Valve's marketing director, Doug Lombardi, the Xbox 360, PlayStation 3 and Windows versions would be identical in functionality and performance. An audio commentary is also featured, as in Episode One and Lost Coast.
Sources: en.wikipedia.org
It is a dual GIP and GLP-1 receptor agonist, frequently grouped with incretin-based peptide therapeutics. It is a peptide rather than a small molecule and is given by subcutaneous injection.
Selective agents engage only the GLP-1 receptor, whereas tirzepatide activates GIP and GLP-1 receptors simultaneously. This difference in receptor coverage is the principal pharmacological distinction emphasised in comparative reviews.
Downstream signalling is partly characterised, but the quantitative contribution of GIP versus GLP-1 receptor activation to metabolic outcomes is not settled. Review articles commonly flag this as an unresolved question rather than a settled finding.
It binds and activates both the GIP and GLP-1 receptors, making it a dual incretin receptor agonist. Single-receptor GLP-1 agonists act on one target only. The dual profile is the defining pharmacological feature of the molecule.